Outcomes of lung transplantation for cystic fibrosis in a large UK cohort

Meachery, G.; De Soyza, A.; Nicholson, A.; Parry, G.; Hasan, A.; Tocewicz, K.; Piliay, I.; Clark, S.; Lordan, J. L.; Schueler, S.; Fisher, A. J.; Dark, J. H.; Gould, F. K.; Corns, P. A.; Pillay, T; Corris, P A
August 2008
Thorax;Aug2008, Vol. 63 Issue 8, p725
Academic Journal
journal article
Background: Lung transplantation is an important option to treat patients with advanced cystic fibrosis (CF) lung disease. The outcomes of a large UK cohort of CF lung transplantation recipients is reported. Methods: Retrospective review of case notes and transplantation databases. Results: 176 patients with CF underwent lung transplantation at our centre. The majority (168) had bilateral sequential lung transplantation. Median age at transplantation was 26 years. Diabetes was common pretransplantation (40%). Polymicrobial infection was common in individual recipients. A diverse range of pathogens were encountered, including the Burkholderia cepacia complex (BCC). The bronchial anastomotic complication rate was 2%. Pulmonary function (forced expiratory volume in 1 s % predicted) improved from a pretransplantation median of 0.8 l (21% predicted) to 2.95 l (78% predicted) at 1 year following transplantation. We noted an acute rejection rate of 41% within the first month. Our survival values were 82% survival at 1 year, 70% at 3 years, 62% at 5 years and 51% at 10 years. Patients with BCC infection had poorer outcomes and represented the majority of those who had a septic death. Data are presented on those free from these infections. Bronchiolitis obliterans syndrome (BOS) and sepsis were common causes of death. Freedom from BOS was 74% at 5 years and 38% at 10 years. Biochemical evidence of renal dysfunction was common although renal replacement was infrequently required (<5%). Conclusion: Lung transplantation is an important therapeutic option in patients with CF even in those with more complex microbiology. Good functional outcomes are noted although transplantation associated morbidities accrue with time.


Related Articles

  • Lung transplantation in adolescents and young adults with cystic fibrosis. Yorke, Janelle; Parle, Michael; James, Melveta; Gay, Tatiana; Harkess, Michelle; Glanville, Allan // Progress in Transplantation;Dec2006, Vol. 16 Issue 4, p343 

    Context--Little is known about adolescents' and young adults' experience with cystic fibrosis while waiting for or after receiving a lung transplant. The psychological and psychosocial factors that may influence these patients' transplant outcomes are yet to be fully explored. Objective--To...

  • Fatal Outcome of Lung Transplantation in Cystic Fibrosis Patients due to Small-Colony Variants of the Burkholderia cepacia Complex. Hä;uβler, S.; Lehmann, C.; Breselge, C.; Rohde, M.; Claβen, M.; Tümmler, B.; Vandamme, P.; Steinmetz, I. // European Journal of Clinical Microbiology & Infectious Diseases;Apr2003, Vol. 22 Issue 4, p249 

    The aim of this study was to investigate the possible role of small-colony variant morphotypes of Burkholderia cepacia-like organisms in infectious complications in cystic fibrosis patients following lung transplantation. Respiratory tract specimens from 470 cystic fibrosis patients were...

  • Cystic fibrosis: lung transplantation. A new option -- a new dilemma! Wells, F.; Caine, N.; Sharples, L.; Wallwork, J. // Journal of the Royal Society of Medicine (Supplement);Jan1992, Vol. 85 Issue 19, p9 

    The article discusses the dilemma in conducting heart and lung transplantation (HLT) on patients with cystic fibrosis who have developed chronic pulmonary infection. It cites the results of HLT technique applied to patients with CF. It explains the procedures involved in double sequential single...

  • Clinical outcome following lung transplantation in patients with cystic fibrosis colonised with Burkholderia cepacia complex: results from two French centres. Boussaud, V.; Guillemain, R.; Grenet, D.; Coley, N.; Souilamas, R.; Bonnette, P.; Stern, M. // Thorax;Aug2008, Vol. 63 Issue 8, p732 

    Background: Infection with Burkholderia cepacia complex (BCC) is a life threatening complication of cystic fibrosis (CF), often seen as a contraindication for lung transplantation. Methods: A long term retrospective study was conducted of all patients with CF undergoing lung transplants from...

  • Transplantation using lung lobes from living donors. Hodson, Margaret E. // Journal of Medical Ethics;Dec2000, Vol. 26 Issue 6, p419 

    Discusses the importance of lung lobe donation to patients suffering from cystic fibrosis (CF). Survival rate of CF patients who undergone lung lobe transplant; How a living lung lobe transplant should be arranged; Ethical dilemmas of lung lobe transplant.

  • Lung Transplantation for Cystic Fibrosis: Additional Considerations. Vittone, Sarah // Pediatric Nursing;Jan/Feb2001, Vol. 27 Issue 1, p90 

    Provides an overview on the actual process which children with cystic fibrosis and their families go through with the lung transplantation procedure. Details on the procedure; Significance of the involvement of the child in the decision making; Implications of the decision for transplant on the...

  • The Prince Charles Hospital ex-vivo lung perfusion (EVLP) -- improving the future for lung transplant. Davies, Belinda; Porra, Margaret; Leisfield, Trish // Transplant Journal of Australasia;Mar2015, Vol. 24 Issue 1, p10 

    No abstract available.

  • Anesthesia for lung transplantation. Miranda, Allen; Zink, Robert; McSweeney, Mary // Seminars in Cardiothoracic & Vascular Anesthesia;Sep2005, Vol. 9 Issue 3, p205 

    Lung transplantation is the only therapeutic option for more than 3,000 individuals in the United States with end-stage lung disease. Innovations in anesthetic and surgical techniques have expanded the indications for lung transplantation. Presently, the major limiting factor in the number of...

  • Lung transplantation for cystic fibrosis. Aurora, Paul // Journal of the Royal Society of Medicine (Supplement);Jun2007, Vol. 100 Issue 47, p46 

    The article focuses on the selection criteria of lung transplant candidates for lung transplantation (LTx) as a treatment for adults and children with end-stage cystic fibrosis (CF) lung disease. Approximately 30% of 1700 lung transplantations are done for patients with CF lung disease. Among...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics